Early Pseudoprogression following Chemoradiotherapy in Glioblastoma Patients: The Value of RANO Evaluation
Figure 4
Kaplan-Meier analysis of progression-free survival curves according to different progression groups: true-progressive disease (tPD), blue; pseudoprogression (psPD), green; nonprogressive disease (nPD), yellow; and different response assessment criteria: (a) Macdonald and (b) RANO.
